Bluejay Diagnostics, Inc. Common Stock (BJDX) is a publicly traded Healthcare sector company. As of May 21, 2026, BJDX trades at $1.69 with a market cap of $1.78M and a P/E ratio of -0.11. BJDX moved +0.00% today. Year to date, BJDX is -32.95%; over the trailing twelve months it is -76.73%. Its 52-week range spans $1.62 to $49.80. Rallies surfaces BJDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BJDX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BJDX recently traded at $1.69. Market cap is $1.78M. P/E ratio is -0.11. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $1.69 |
| Market Cap | $1.78M |
| P/E Ratio | -0.11 |
| EPS | $-15.25 |
| Dividend Yield | 0.00% |
| 52-Week High | $49.80 |
| 52-Week Low | $1.62 |
| Volume | 17 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-6.85M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-6.85M | $-15.25 |
| 2024 | $0 | $-7.72M | $-114.19 |
| 2023 | $0 | $-9.95M | $-9.08 |
| 2022 | $249.04K | $-9.30M | $-0.46 |
BJDX analyst coverage data. Average price target: $0.00.